The UCSF Graduate Program in Biomedical Sciences is an interdisciplinary program that trains students for research careers investigating the molecular basis of tissue and organ function in health and disease. It offers a novel integrative curriculum, designed specifically for graduate students, which provides a foundation in cell biology, molecular biology, genetics, and biochemistry as applied to research problems in human developmental biology, physiology, and disease. Training is supported by laboratory rotations, journal clubs, and research seminars. The program's faculty consists of 110 members drawn from both basic science and clinical departments. Their research interests are broad, but focused into eight thematic areas: Cancer Biology and Cell Signaling, Human Genetics, Vascular and Cardiac Biology, Developmental and Stem Cell Biology, Immunology, Microbial Pathogenesis and Virology, Neuroscience, and Tissue/Organ Biology and Endocrinology. Trainees are chosen from a national applicant pool, with special effort to include underrepresented minorities. The interdisciplinary spirit of the program reflects the interactive scientific culture at UCSF.

Public Health Relevance

Trainees study multiple human diseases including cancer, cardiovascular disease, developmental disorders, infectious diseases (such as AIDS), immunological diseases (such as asthma), diabetes and neurological disorders. The broad training allows graduates to develop careers in academia identifying molecular and cellular underpinnings of major human diseases or in the biotech sector developing novel therapeutics.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Maas, Stefan
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Francisco
Schools of Medicine
San Francisco
United States
Zip Code
Camarda, Roman; Zhou, Alicia Y; Kohnz, Rebecca A et al. (2016) Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer. Nat Med 22:427-32
Mazor, Tali; Pankov, Aleksandr; Song, Jun S et al. (2016) Intratumoral Heterogeneity of the Epigenome. Cancer Cell 29:440-51
Shaby, Benjamin A; Skibinski, Gaia; Ando, Michael et al. (2016) A three-groups model for high-throughput survival screens. Biometrics 72:936-44
Eriksen, Jacob; Chang, Roger; McGregor, Matt et al. (2016) Protons Regulate Vesicular Glutamate Transporters through an Allosteric Mechanism. Neuron 90:768-80
Louie, Sharon M; Grossman, Elizabeth A; Crawford, Lisa A et al. (2016) GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity. Cell Chem Biol 23:567-78
Cain, Corey J; Valencia, Joel T; Ho, Samantha et al. (2016) Increased Gs Signaling in Osteoblasts Reduces Bone Marrow and Whole-Body Adiposity in Male Mice. Endocrinology 157:1481-94
Stieglitz, Elliot; Taylor-Weiner, Amaro N; Chang, Tiffany Y et al. (2016) Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet 48:101
Lee, Sangmi; Mattingly, Aaron; Lin, Amity et al. (2016) A novel antagonist of p75NTR reduces peripheral expansion and CNS trafficking of pro-inflammatory monocytes and spares function after traumatic brain injury. J Neuroinflammation 13:88
Krishnakumar, Raga; Chen, Amy F; Pantovich, Marisol G et al. (2016) FOXD3 Regulates Pluripotent Stem Cell Potential by Simultaneously Initiating and Repressing Enhancer Activity. Cell Stem Cell 18:104-17
Bell, Robert J A; Rube, H Tomas; Xavier-Magalhães, Ana et al. (2016) Understanding TERT Promoter Mutations: A Common Path to Immortality. Mol Cancer Res 14:315-23

Showing the most recent 10 out of 44 publications